ISMB 2020 - Distinguished Keynote
Elaine R. Mardis
The Steve and Cindy Rasmussen Nationwide Foundation Endowed Chair in Genomic Medicine
Co-Executive Director, The Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children's Hospital
Professor of Pediatrics
The Ohio State University College of Medicine
Columbus, United States
Introduced by: Francis Ouellette, Conference Co-chair
Time: Monday, July 13, 9:30 am - 10:30 am (Eastern Daylight Time)
Presentation Title: Computational Analysis in Pediatric Cancer Precision Medicine
Computational analysis provides a critical component for cancer NGS data evaluation, identification of variants and their interpretation, as well as databasing and data sharing. Further refinements in the context of immunogenomic analyses further expand the toolkit for precision medicine evaluation. My lecture will illustrate how the interplay of data and analytics produces a high yield of medically meaningful data.
Elaine Mardis, PhD is co-Executive Director of the Institute for Genomic Medicine at Nationwide Children’s Hospital and the Nationwide Foundation Endowed Chair of Genomic Medicine. She also is Professor of Pediatrics at The Ohio State University College of Medicine. Dr. Mardis joined Nationwide Children’s Hospital in 2016. Educated at the University of Oklahoma with a B.S. in Zoology and a Ph.D. in Chemistry and Biochemistry, Dr. Mardis did postgraduate work in industry at BioRad Laboratories. She was a member of the faculty of Washington University School of Medicine from 1993-2016.
Dr. Mardis has authored over 350 articles in prestigious peer-reviewed journals and has written book chapters for several medical textbooks. She serves as an associate editor for three peer-reviewed journals (Disease Models and Mechanisms, Molecular Cancer Research, and Annals of Oncology) and is Editor-in-Chief of Molecular Case Studies, published by Cold Spring Harbor Press. Dr. Mardis has given lectures at scientific meetings worldwide and was awarded the Morton K Schwartz award from the American Association for Clinical Chemistry in 2016. She has been listed since 2013 as one of the most highly cited researchers in the world by Thompson Reuters. Dr. Mardis has been a member of the American Association for Cancer Research (AACR) since 2007, was the program committee chair for the 2018 AACR Annual Meeting and is the current AACR President. She was elected a Fellow of the AACR Academy, and also was elected to membership in the National Academy of Medicine in 2019.